Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 5Active not recruiting 5Unknown 2Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 6Glioblastoma 4Colorectal Neoplasms 4Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2Lymphoma, Follicular 2Lymphoma 2Hodgkin Disease 2Ganglioneuroblastoma 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Brain Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Paclitaxel 8Carboplatin 7Tirzepatide 3Observation 3Cisplatin 3pembrolizumab 2dostarlimab 2Megestrol Acetate 2Medroxyprogesterone Acetate 2Blood Specimen Collection 2trilaciclib 1toripalimab 1tislelizumab 1sintilimab 1semaglutide 1olaparib 1montelukast 1inavolisib 1enfortumab vedotin 1ceralasertib 1camrelizumab 1apatinib 1anlotinib 1Watchful Waiting 1Vaginal Smears 1Topotecan 1Tablets 1Specimen Handling 1Sensitivity Training Groups 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Endometrial Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡